The Lipshutz Lab would like to congratulate Rachel Xu, Kiran, and Taryn for their recent publication, “A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: A 100-fold dose reduction compared to AAV alone.” This publication was also featured on a recent ASGCT email newsletter sent to subscribers.